On October 21, 2026, the Stochastic Oscillator for CGEM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In 60 of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over 88%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CGEM's RSI Oscillator exited the oversold zone, 19 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for CGEM just turned positive on October 20, 2026. Looking at past instances where CGEM's MACD turned positive, the stock continued to rise in 45 of 52 cases over the following month. The odds of a continued upward trend are 87%.
Following a +0.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where CGEM advanced for three days, in 206 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
CGEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CGEM as a result. In 82 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
CGEM moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CGEM crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGEM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for CGEM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.984) is normal, around the industry mean (2.973). P/E Ratio (-4.797) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. CGEM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
KYMR saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 64 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.
The Moving Average Convergence Divergence (MACD) for KYMR just turned positive on October 20, 2026. Looking at past instances where KYMR's MACD turned positive, the stock continued to rise in 36 of 45 cases over the following month. The odds of a continued upward trend are 80%.
Following a +8.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where KYMR advanced for three days, in 242 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
KYMR moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for KYMR crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
KYMR broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for KYMR entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.107) is normal, around the industry mean (2.973). P/E Ratio (-34.108) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (103.093) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. KYMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
KYMR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 50 | |
SMR RATING 1..100 | 95 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 40 | |
SEASONALITY SCORE 1..100 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CGEM | KYMR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | N/A |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 64% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 80% |
| TrendWeek ODDS (%) | 1 day ago 76% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 85% |
| Advances ODDS (%) | 1 day ago 76% | 3 days ago 82% |
| Declines ODDS (%) | 9 days ago 87% | 1 day ago 86% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 87% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 78% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CGEM’s FA Score shows that 2 FA rating(s) are green while KYMR’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CGEM’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).
CGEM (@Biotechnology) experienced а +6.57% price change this week, while KYMR (@Biotechnology) price change was +5.43% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
CGEM is expected to report earnings on Nov 05, 2026.
KYMR is expected to report earnings on Nov 03, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with CABA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then CABA could also see price increases.
| Ticker / NAME | Correlation To CGEM | 1D Price Change % | ||
|---|---|---|---|---|
| CGEM | 100% | +0.20% | ||
| CABA - CGEM | 49% Loosely correlated | -1.30% | ||
| RAPP - CGEM | 49% Loosely correlated | +5.87% | ||
| RCKT - CGEM | 48% Loosely correlated | +5.00% | ||
| RLAY - CGEM | 47% Loosely correlated | -0.38% | ||
| LXEO - CGEM | 46% Loosely correlated | -3.67% | ||
More | ||||
A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with GPCR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then GPCR could also see price increases.
| Ticker / NAME | Correlation To KYMR | 1D Price Change % | ||
|---|---|---|---|---|
| KYMR | 100% | -1.58% | ||
| GPCR - KYMR | 63% Loosely correlated | -0.36% | ||
| NRIX - KYMR | 58% Loosely correlated | -1.96% | ||
| WVE - KYMR | 52% Loosely correlated | -0.59% | ||
| CGEM - KYMR | 44% Loosely correlated | +0.20% | ||
| REPL - KYMR | 44% Loosely correlated | +2.30% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GOVT | 22.24 | 0.18 | +0.79% |
| iShares U.S. Treasury Bond ETF (GOVT) | |||
| GII | 73.40 | 0.18 | +0.25% |
| State Street SPDR S&P Global Infrastructure ETF (GII) | |||
| DVGR | 26.77 | 0.06 | +0.23% |
| DAC 3D Dividend Growth ETF (DVGR) | |||
| NELS | 28.86 | -0.40 | -1.37% |
| Nelson Select ETF (NELS) | |||
| HBTA | 31.49 | -1.10 | -3.38% |
| Horizon Expedition Plus ETF | |||